Wells Fargo’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Wells Fargo’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-66,500	Closed	-$1.02M	–	7362
2025 Q1	$1.02M	Sell	66,500 -44,500	-40%	-$795K	﹤0.01%	3642
2024 Q4	$2.45M	Sell	111,000 -64,000	-37%	-$1.16M	﹤0.01%	3045
2024 Q3	$3.15M	Buy	+175,000	New	+$3.06M	﹤0.01%	2721
2023 Q2	–	Sell	-250,000	Closed	-$2.21M	–	7694
2023 Q1	$2.21M	Hold	250,000	–	–	﹤0.01%	2782
2022 Q4	$2.28M	Buy	+250,000	New	+$2.18M	﹤0.01%	2685
2021 Q3	–	Sell	-191,100	Closed	-$1.89M	–	7513
2021 Q2	$1.89M	Buy	+191,100	New	+$2.02M	﹤0.01%	3732
2021 Q1	–	Sell	-200,000	Closed	-$185K	–	7365
2020 Q4	$185K	Buy	+200,000	New	+$1.92M	﹤0.01%	5117
2020 Q2	–	Sell	-972,500	Closed	-$1.73M	–	6815
2020 Q1	$1.73M	Buy	972,500 +12,200	+1%	+$125K	﹤0.01%	3131
2019 Q4	$210K	Buy	960,300 +770,700	+406%	+$6.88M	﹤0.01%	4925
2019 Q3	$271K	Buy	+189,600	New	+$1.45M	﹤0.01%	4774
2019 Q1	–	Sell	-142,500	Closed	-$23K	–	6442
2018 Q4	$23K	Buy	142,500 +42,500	+43%	+$871K	﹤0.01%	5749
2018 Q3	$54K	Buy	100,000 +50,000	+100%	+$1.16M	﹤0.01%	5572
2018 Q2	$8K	Sell	50,000 -100,000	-67%	-$2.04M	﹤0.01%	6008
2018 Q1	$143K	Buy	+150,000	New	+$2.93M	﹤0.01%	5153
2017 Q4	–	Sell	-92,500	Closed	-$1.99M	–	6520
2017 Q3	$1.99M	Hold	92,500	–	–	﹤0.01%	3320
2017 Q2	$669K	Sell	92,500 -500	-0.5%	-$15.5K	﹤0.01%	4027
2017 Q1	$807K	Sell	93,000 -25,400	-21%	-$867K	﹤0.01%	3907
2016 Q4	$663K	Buy	118,400 +118,000	+29,500%	+$4.71M	﹤0.01%	4013
2016 Q3	$1K	Sell	400 -404,000	-100%	-$21.1M	﹤0.01%	6121
2016 Q2	$2.33M	Buy	+404,400	New	+$21.5M	﹤0.01%	2856
2016 Q1	–	Sell	-75,000	Closed	-$3K	–	6418
2015 Q4	$3K	Hold	75,000	–	–	﹤0.01%	5976
2015 Q3	$234K	Sell	75,000 -80,000	-52%	-$5.19M	﹤0.01%	4378
2015 Q2	$672K	Buy	+155,000	New	+$9.56M	﹤0.01%	3902
2014 Q4	–	Sell	-100,000	Closed	-$913K	–	6405
2014 Q3	$913K	Buy	+100,000	New	+$5.3M	﹤0.01%	3530
2014 Q1	–	Sell	-700	Closed	-$1K	–	6068
2013 Q4	$1K	Buy	+700	New	+$27.6K	﹤0.01%	5639

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Wells Fargo's TEVA Position: Q2 2026 in Review

Wells Fargo reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 8.9% in Q2 2026, selling an estimated $1.44M and leaving 443,900 shares worth $15M. The position accounts for ﹤0.01% of the portfolio, ranked #1872.

Wells Fargo first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $183M in Q1 2015. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Wells Fargo held 443,900 shares of Teva Pharmaceutical Industries Limited worth $15M as of Q2 2026.
Wells Fargo sold 43,118 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $1.44M.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #1872 holding.
Wells Fargo first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 53 quarters since.
Wells Fargo's Teva Pharmaceutical Industries Limited position peaked at $183M in Q1 2015.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.